Search Within

GSK Faculty

Formats
  1. Journal Article (13944)
  2. Meeting Abstract (7136)
  3. Review (527)
  4. Book Section (346)
  5. Editorial (315)
  6. Conference Paper (163)
  7. Research Letter (96)
  8. Miscellaneous (46)
  9. Correspondence (38)
  10. Guidelines (33)
  11. Book Whole (24)
Groups
  1. Sloan Kettering Institute Faculty (11549)
  2. Department of Medicine (10634)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (8368)
  4. Tow Center for Developmental Oncology (TCDO) (7015)
  5. Sloan Kettering Institute Postdocs (6319)
  6. Solid Tumor Oncology Division (5936)

More Groups

People
  1. Marc Ladanyi (1334)
  2. Steven Larson (960)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (903)
  5. Kenneth Offit (791)
  6. Ross Levine (786)

More People

Years
  1. 2025 (466)
  2. 2024 (904)
  3. 2023 (1015)
  4. 2022 (1148)
  5. 2021 (1087)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1506)
  2. Journal of Clinical Oncology (1295)
  3. Cancer Research (1105)
  4. Clinical Cancer Research (531)
  5. Modern Pathology (497)
  6. Journal of Nuclear Medicine (476)

More Publications

Publishers
  1. Nature Publishing Group (2628)
  2. American Association for Cancer Research (2205)
  3. Elsevier Inc. (1939)
  4. American Society of Hematology (1590)
  5. Cell Press (1442)
  6. American Society of Clinical Oncology (1398)

More Publishers

Results (22668)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304
    Meeting Abstract

    Rudin, C. M.; Mountzios, G. S.; Sun, L.; Cho, B. C.; Demirci, U.; Baka, S.; Gumus, M.; Lugini, A.; Ciuleanu, T. E.; Ahn, M. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Hyddmark, E. M. V.; Berry, D. A.; Berry, N. S.; Colman, H.; de Groot, J. F.; Ellingson, B. M.; Gan, H. K.; Johnson, A.; Lassman, A. B.; Lim, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769)
    Meeting Abstract

    Traina, T. A.; Chen, Y.; Khoury, K.; Rugo, H. S.; Mayer, E. L.; Abdou, Y.; Melisko, M. E.; Pareja, F.; Weigelt, B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Intrathecal deferoxamine in patients with leptomeningeal metastases: Phase 1a analysis
    Meeting Abstract

    Wilcox, J.; Reiner, A. S.; Young, R. J.; Emadi-Paramkouhi, L.; Weill, B.; Myers, L.; Tulca, Y.; Gonzalez, A.; Estrera, R.; Osei-Gyening, I.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Tumor-wide RNA splicing aberrations and their potential as therapeutic neoantigen targets
    Meeting Abstract

    Kwok, D.; Stevers, N.; Etxeberria, I.; Nejo, T.; Cove, M. C.; Chen, L.; Jung, J.; Okada, K.; Lakshmanachetty, S.; Gallus, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Genomic predictors of brain metastases in breast cancer
    Meeting Abstract

    Safonov, A.; Smith, D. R.; Nandakumar, S.; Ferraro, E.; Shen, J.; Khatri, I. S.; Kumar, R.; An, J. A. R.; Jee, J.; Robson, M. E.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Use of a large language model (LLM) for pan-cancer automated detection of anti-cancer therapy toxicities and translational toxicity research
    Meeting Abstract

    Bakouny, Z.; Ahmed, N.; Fong, C.; Rahman, A.; Perea-Chamblee, T.; Pichotta, K.; Waters, M.; Fu, C.; Jeng, M. Y.; Lee, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effect of ERBB2 activating mutations on enhanced internalization and activity of trastuzumab deruxtecan in HER2-non-amplified metastatic breast cancer
    Meeting Abstract

    Mai, N.; Liu, B.; Safonov, A.; Shen, S.; Zelizer, S.; White, C.; Chen, Y.; Razavi, P.; Jhaveri, K. L.; Modi, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Ultrasensitive ctDNA monitoring during CDK4/6 inhibitor therapy for metastatic breast cancer
    Meeting Abstract

    Ah-Reum An, J.; Jasper, J.; Cabel, L.; Yildirim, S. Y.; da Silva, E. M.; Patel, R. K.; LaBella, M.; Teysir, J.; Mai, N.; Safonov, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Circulating tumor DNA (ctDNA) dynamics as a predictor of treatment response in metastatic breast cancer (mBC)
    Meeting Abstract

    Razavi, P.; Cabel, L.; Teysir, J.; An, J. A. R.; Rivero-Hinojosa, S.; Satta, S.; Bristow, S. L.; Kalashnikova, E.; Rodriguez, A. A.; Liu, M. C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save